I have written somewhat gloomily about the counterfeit drug trade several times and specifically about the widely held belief that whatever steps the industry takes, the pirates seem to be one or two ahead. Interpol shut down a massive 10,000 websites selling illegal prescription drugs in May alone, but this is only scratching the surface.
The trade in fake erectile dysfunction drugs is especially strong. After all, few men would relish the thought of mentioning their particular problems to a doctor. The idea of getting hold of ED drugs without prescription is seen as a good way to cut the embarrassment. Sanofi seems to agree. It plans to launch an over-the-counter version of Lily’s Cialis.
The timing is ideal as Cialis patents are due to start expiring in 2017 and Viagra has already lost its exclusivity in many markets. There are already numerous legitimate pharmacies offering a form of fast-track way to obtain these drugs but these usually still rely on a doctor’s assessment.
Pfizer did try to launch a European OTC Viagra in 2008 but withdrew the application in face of demands for additional data. Instead, it has launched a direct to consumer web service with enticing special offers and deals for repeat purchasers.
Could this approach be an effective way to combat internet drug fraud? Of course the vast majority of drugs will always need the strict control offered by using the medical profession as gatekeepers. However, the direct to consumer approach could become more popular.
AstraZeneca has already started delivering its Nexium indigestion remedy direct to patients so who knows?
|
|
 |
|
|
Share on LinkedIn |
Share via Email |
